Document is current

Article History

Received: 9 January 2026

Accepted: 2 April 2026

First Online: 7 May 2026

Declarations

:

: Christopher Wang has nothing to disclose. Ajay Prasad has nothing to disclose. Elizabeth Qi has nothing to disclose. Jonathan Pai has nothing to disclose. Jade Law has nothing to disclose. Krithika Chennapan has nothing to disclose. Grant Jirka has nothing to disclose. Peter Kuhn is affiliated with Cansera. Mihir Tale has nothing to disclose. Luciano Nocera holds stock options in Cansera. Jorge Nieva receives research support from Genentech and Merck, and personal fees from Aadi Biosciences, AstraZeneca, ANP Technologies, BioAtla, BMS, Catalym, G1 Therapeutics, Gilead, Genentech, Kalivir, Mindmed, Naveris, Sanofi, Tubulis, and Urogen. He has ownership interests in Affyyimmune, Cansera, Indee Bio, Quantgene, Amgen, Johnson & Johnson, and Novartis, and holds intellectual property licensed to Cansera.

: This study received ethical approval from the University of Southern California Health Sciences Institutional Review Board (Approval #HS-22-00537) on November 14th, 2022. The study was conducted in accordance with the ethical principles of the Declaration of Helsinki in 1964 and its subsequent amendments. All study participants gave written informed consent prior to study activities. All participants were aware that the data from their participation would be used for published studies, and were explicitly informed that opting out of the study would in no way impact their future care.